Case report: Infective endocarditis caused by Streptococcus pneumonia at Prof. Ngoerah Hospital, Denpasar, Bali
Abstract
Introduction: Infective endocarditis (IE) is a rare infection of the endocardial surface that can be caused by Streptococcus pneumoniae (pneumococcal endocarditis/PE), with an incidence of between 1.4–12.7 per 100,000 people each year, and a mortality rate of <3%. Infective endocarditis is associated with several complications including stroke and congestive heart failure. Here we report a case of IE in an adult caused by S. pneumoniae. Case Description: A 27-year-old woman complained of swelling in both legs, red spots, and a history of fever since 2 days before admission. Physical and supporting examinations including echocardiography and three-sided blood culture were carried out using VITEK-2. Streptococcus pneumoniae was identified from the culture which sensitive to Benzylpenicillin group including Cefotaxime, Ceftriaxone, Levofloxacin, Erythromycin, Clindamycin, Tetracycline, and Trimethoprim/Sulfamethoxazole. Infective endocarditis due to S. pneumoniae in adult is very rare. The attachment of S. pneumoniae to the heart valve, may be facilitated by its capsule, which is considered essential in bacteremia. Patient received empirical intravenous antibiotics with 3 grams Ampicillin every 6 hours and 150 mg Gentamicin every 24 hours. The patient improved and treatment was continued by intramuscular injections of 1.2 million IU Benzathine Penicillin G were given every 28 days until age 40. Conclusion: Infective endocarditis cases in adult patients are associated with high…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health. Reported size: 100,000 participants or records.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.